Anagnostics enters sales cooperation with Analis S.A. for Belgium and Luxembourg

The Belgian company is specialized on clinical diagnostics and distributes Anagnostics’ innovative laboratory in the areas of drugs of abuse screening, personalized medicine (oncology) and sepsis diagnostics.

Online PR News – 10-December-2012 – St. Valentin/Austria – Since this summer Analis S.A. from SuarlĂ©e (near Namur) offers Anagnostics’ diagnostic products for drugs of abuse screening and personalized medicine. In the coming months the sales portfolio will be enlarged by tests supporting the diagnosis and therapy of sepsis. Analis and Anagnostics aim to serve hospitals in the Belux countries by offering truly innovative products and first class service.

“Analis is specialized on clinical diagnostics for a broad and loyal customer base and emphasizes first class support and advice of customers. Therewith Analis is the ideal partner for the distribution of our laboratory tests in Belgium and Luxembourg”, comments Christoph Reschreiter, CEO of Anagnostics Bioanalysis GmbH.
Guy Stukkens, CEO of Analis S.A. is looking forward to the sales cooperation:

„We clearly see the trend towards more specific as well as more targeted and faster diagnostics, which is offered by multiplexed diagnostics. Anagnostics reacted on this need perfectly well. With the hyborg device and the test portfolio Anagnostics offers good market opportunities. The fast and efficient testing of drugs of abuse consumption ensures access to therapy institutions. The simple and highly sensitive tests in personalized medicine are particularly advantageous for small and medium sized pathologies, because cost efficiency is ensured even with low sample numbers.”

Multiplexed diagnostics with focus on clinical use
Anagnostics Bioanalysis with its headquarters in St. Valentin (Austria) is specialized in developing systems, devices and tests in drugs of abuse screening, pharmacogenetics (oncology) and tests for diagnosing severe infections. With the unique ability to perform protein as well as DNA based assays the hyborg system offers a testing platform meeting needs of personalized medicine and integrated diagnostics.
Anagnostics was established in 2005 by Bernhard Ronacher, a molecular genetics scientist. A cylindrical microarray – the hybcell - is the core of the patented multiplex technology. Combined with the hyborg analysis system multi-parameter assays are performed in a fully automated manner.

Distribution and sales specialist for modern diagnostics
Especially in Belgium, Analis S.A. (from Suarlée near Namur, Belgium) is well known for distribution and service of modern diagnostic technologies and tests. The company was founded in 1927 and employs 140 people in sales, service and support. Analis strives to maintain a highly professional level; therefore much effort is put in education of employees.

Press contacts:
Impuls Public Relations OG | Mag. Anita Reschreiter
A-4020 Linz BĂĽrgerstraĂźe 26./1.OG | Tel. +43 (0)664/1604209

Anagnostics Bioanalysis GmbH | Mag. Christoph Reschreiter
A-4300 St. Valentin/Austria | Westbahnstrasse 55 | Tel. +43 (0)7435 58193-0